Analyze Diet
Australian veterinary journal2011; 89 Suppl 1; 135-137; doi: 10.1111/j.1751-0813.2011.00735.x

Equine influenza: patterns of disease and seroprevalence in Thoroughbred studs and implications for vaccination.

Abstract: This study included 10 large Thoroughbred horse studs in the upper Hunter Valley of New South Wales and in southeast Queensland, Australia. The aims were to describe the EI epidemic in studs in the Special Restricted Area (Purple Zone) of NSW, to estimate seroprevalence among different groups of horses on these studs and to look for evidence of exposure to EI virus in horses on 'vaccinated' studs in southeast Queensland that were thought to have remained free of infection. As serology results from Queensland suggest that vaccination may have reduced the sensitivity of clinical surveillance to detect the presence of infection on 'vaccinated' premises, we conclude that vaccine efficacy must be considered in terms of reduction in clinical disease, as well as in terms of infection and infectiousness.
Publication Date: 2011-07-08 PubMed ID: 21711311DOI: 10.1111/j.1751-0813.2011.00735.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on evaluating the prevalence and patterns of Equine Influenza (EI) in Thoroughbred studs in Australia, and the impact of vaccination on disease detection and prevention.

Study Description and Aims

  • The research was conducted in ten large Thoroughbred horse studs located in the upper Hunter Valley of New South Wales and in southeast Queensland, Australia.
  • The study aimed to describe the EI epidemic among studs in the Special Restricted Area, referred to as Purple Zone, of New South Wales.
  • Additionally, the intent was to estimate the level of EI presence (seroprevalence) among diverse groups of horses within these studs.
  • The study also sought to examine signs of exposure to the EI virus among horses in ‘vaccinated’ studs in southeast Queensland that were assumed to have remained uninfected.

Serology Results and Implications for Vaccination

  • Serology is the study of body fluids, like blood, to detect the presence of antibodies against viruses such as EI. The serology results from this study suggested reduced sensitivity of clinical surveillance in detecting infection in ‘vaccinated’ premises.
  • This outcome indicates that the vaccination protocol may hamper the accurate detection of the EI virus among vaccinated horse populations. This can lead to a false impression of a disease-free environment while the virus may still be present.
  • The researchers concluded that when considering vaccine efficacy, it’s important to not only evaluate the reduction in clinical disease but also take into account the infection and infectiveness rates. This approach would give a more comprehensive understanding of the vaccine’s effectiveness in controlling the disease in horse populations.

Impact on Future Vaccination Strategies

  • The findings of this study can significantly influence future strategies for EI vaccination among horse herds. Understanding the limitations of current vaccination measures in accurately detecting disease incidence can help inform more effective management practices.
  • Such knowledge can guide the modification of existing vaccination protocols to increase their sensitivity and specificity, thereby improving overall disease management in domestic horse populations.

Cite This Article

APA
Happold J, Rubira R. (2011). Equine influenza: patterns of disease and seroprevalence in Thoroughbred studs and implications for vaccination. Aust Vet J, 89 Suppl 1, 135-137. https://doi.org/10.1111/j.1751-0813.2011.00735.x

Publication

ISSN: 1751-0813
NlmUniqueID: 0370616
Country: England
Language: English
Volume: 89 Suppl 1
Pages: 135-137

Researcher Affiliations

Happold, J
  • Office of Chief Veterinary Officer, Australian Government Department of Agriculture Fisheries and Forestry, Canberra 2600, Australian Capital Territory, Australia. Jonathan.Happold@daff.gov.au
Rubira, R

    MeSH Terms

    • Animals
    • Australia / epidemiology
    • Disease Outbreaks / veterinary
    • Female
    • Horse Diseases / epidemiology
    • Horse Diseases / virology
    • Horses
    • Influenza A Virus, H3N8 Subtype / isolation & purification
    • Influenza Vaccines / administration & dosage
    • Male
    • Orthomyxoviridae Infections / epidemiology
    • Orthomyxoviridae Infections / veterinary
    • Seroepidemiologic Studies
    • Surveys and Questionnaires
    • Vaccination / methods
    • Vaccination / standards
    • Vaccination / veterinary

    Citations

    This article has been cited 3 times.
    1. Paillot R, El-Hage CM. The Use of a Recombinant Canarypox-Based Equine Influenza Vaccine during the 2007 Australian Outbreak: A Systematic Review and Summary. Pathogens 2016 Jun 10;5(2).
      doi: 10.3390/pathogens5020042pubmed: 27294963google scholar: lookup
    2. Paillot R. A Systematic Review of Recent Advances in Equine Influenza Vaccination. Vaccines (Basel) 2014 Nov 14;2(4):797-831.
      doi: 10.3390/vaccines2040797pubmed: 26344892google scholar: lookup
    3. Chambers TM. Equine Influenza. Cold Spring Harb Perspect Med 2022 Jan 4;12(1).
      doi: 10.1101/cshperspect.a038331pubmed: 32152243google scholar: lookup